Clinical and molecular characterizations of 11 new patients with type 1 Feingold syndrome: Proposal for selecting diagnostic criteria and further genetic testing in patients with severe phenotype. Issue 4 (14th January 2021)

• Record Type: Journal Article
• Authors: Tedesco, Maria Giovanna; Lonardo, Fortunato; Ceccarini, Caterina; Cesarano, Carla; Digilio, Maria Cristina; Magliozzi, Monia; Rogaia, Daniela; Mencarelli, Amedea; Leoni, Chiara; Piscopo, Carmelo; Imperatore, Valentina; Falco, Maria Teresa; Fontana, Paolo; Nardone, Anna Maria; Novelli, Antonio; Troiani, Stefania; Seri, Marco; Prontera, Paolo
• Is Part Of: American journal of medical genetics. Volume 185:Issue 4(2021)
• Page Start: 1204
• Page End: 1210
• Publication Date: 2021-01-14
• Subjects: brachymesophalangy -- diagnostic criteria -- Feingold syndrome -- microcephaly -- MYCN -- review; Medical genetics -- Periodicals; 616.14205
• DOI: 10.1002/ajmg.a.62068
• Languages: English
• ISSNs: 1552-4825

Abstract

Abstract: Feingold Syndrome type 1 (FS1) is an autosomal dominant disorder due to a loss of function mutations in the MYCN gene. FS1 is generally clinically characterized by mild learning disability, microcephaly, short palpebral fissures, short stature, brachymesophalangy, hypoplastic thumbs, as well as syndactyly of toes, variably associated with organ abnormalities, the most common being gastrointestinal atresia. In current literature, more than 120 FS1 patients have been described, but diagnostic criteria are not well agreed upon, likewise the genotype–phenotype correlations are not well understood. Here, we describe 11 FS1 patients, belonging to six distinct families, where we have identified three novel MYCN mutations along with three pathogenetic variants, the latter which have already been reported. Several patients presented a mild phenotype of the condition and they have been diagnosed as being affected only after segregation analyses of the MYCN mutation identified in the propositus. We also describe here the first ever FS1 patient with severe intellectual disability having a maternally inherited MYCN variant together with an additional GNAO1 mutation inherited paternally. Mutations in the GNAO1 gene are associated with a specific form of intellectual disability and epilepsy, thus the finding of two different rare diseases in the same patient could explain his severe phenotype. Therein, a thorough investigation is merited into the possibility that additional variants in patients with a MYCN mutation and severe phenotype do exist. Finally, in order to guarantee a more reliable diagnosis of FS1, we suggest using both major and minor clinical‐molecular diagnostic criteria.